Structure Principles of CRISPR-Cas Surveillance and Effector Complexes

被引:17
|
作者
Tsui, Tsz Kin Martin [1 ]
Li, Hong
机构
[1] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA
来源
关键词
DNA interference; RNA silencing; ribonucleoprotein particles; prokaryote immunity; RNA-SILENCING COMPLEX; ANTIVIRAL DEFENSE; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; INTERFERENCE COMPLEX; ADAPTIVE IMMUNITY; DNA ENDONUCLEASE; CMR COMPLEX; DUAL-RNA; CLEAVAGE;
D O I
10.1146/annurev-biophys-060414-033939
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The pathway of CRISPR-Cas immunity redefines the roles of RNA in the flow of genetic information and ignites excitement for next-generation gene therapy tools. CRISPR-Cas machineries offer a fascinating set of new enzyme assemblies from which one can learn principles of molecular interactions and chemical activities. The interference step of the CRISPR-Cas immunity pathway congregates proteins, RNA, and DNA into a single molecular entity that selectively destroys invading nucleic acids. Although much remains to be discovered, a picture of how the interference process takes place is emerging. This review focuses on the current structural data for the three known types of RNA-guided nucleic acid interference mechanisms. In it, we describe key features of individual complexes and we emphasize comparisons across types and along functional stages. We aim to provide readers with a set of core principles learned from the three types of interference complexes and a deep appreciation of the diversity among them.
引用
收藏
页码:229 / 255
页数:27
相关论文
共 50 条
  • [11] Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes
    Mueller-Esparza, Hanna
    Osorio-Valeriano, Manuel
    Steube, Niklas
    Thanbichler, Martin
    Randau, Lennart
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [12] Type III CRISPR-Cas: beyond the Cas10 effector complex
    Stella, Gianna
    Marraff, Luciano
    TRENDS IN BIOCHEMICAL SCIENCES, 2024, 49 (01) : 28 - 37
  • [13] Defining the seed sequence of the Cas12b CRISPR-Cas effector complex
    Jain, Ishita
    Minakhin, Leonid
    Mekler, Vladimir
    Sitnik, Vasily
    Rubanova, Natalia
    Severinov, Konstantin
    Semenova, Ekaterina
    RNA BIOLOGY, 2019, 16 (04) : 413 - 422
  • [14] Mechanistic determinants and dynamics of cA6 synthesis in type III CRISPR-Cas effector complexes
    Jungfer, Kenny
    Moravcik, Stefan
    Garcia-Doval, Carmela
    Knoerlein, Anna
    Hall, Jonathan
    Jinek, Martin
    NUCLEIC ACIDS RESEARCH, 2025, 53 (02)
  • [15] CRISPR-Cas bioinformatics
    Alkhnbashi, Omer S.
    Meier, Tobias
    Mitrofanov, Alexander
    Backofen, Rolf
    Voss, Bjoern
    METHODS, 2020, 172 : 3 - 11
  • [16] Sabotage of CRISPR-Cas
    Du Toit, Andrea
    NATURE REVIEWS MICROBIOLOGY, 2024, 22 (01) : 1 - 1
  • [17] Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector
    Yangao Huo
    Hongshen Zhao
    Qinghua Dong
    Tao Jiang
    Nature Microbiology, 2023, 8 : 522 - 532
  • [18] Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector
    Huo, Yangao
    Zhao, Hongshen
    Dong, Qinghua
    Jiang, Tao
    NATURE MICROBIOLOGY, 2023, 8 (03) : 522 - 532
  • [19] Structure of a type IV CRISPR-Cas ribonucleoprotein complex
    Zhou, Yi
    Bravo, Jack P. K.
    Taylor, Hannah N.
    Steens, Jurre A.
    Jackson, Ryan N.
    Staals, Raymond H. J.
    Taylor, David W.
    ISCIENCE, 2021, 24 (03)
  • [20] Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System
    Redding, Sy
    Sternberg, Samuel H.
    Marshall, Myles
    Gibb, Bryan
    Bhat, Prashant
    Guegler, Chantal K.
    Wiedenheft, Blake
    Doudna, Jennifer A.
    Greene, Eric C.
    CELL, 2015, 163 (04) : 854 - 865